Biomay AG   The company is a Vienna based biotech company and the hub of an Austrian allergy research and development network. Scientists at the Medical University of Vienna and the University of Salzburg – the two most important network partners – have been pursuing RESEARCH FOR BETTER ALLERGY THERAPEUTICS AND DIAGNOSTICS for over 20 years. Our STRENGTH is its proprietary technology platform and its strong product pipeline. Molecules from this platform have successfully passed phase II clinical trials for allergy vaccines. We also offers GMP contract manufacturing services for pre-clinical development and clinical trial material. The production facility is certified for manufacturing of microbial-based biopharmaceuticals such as recombinant proteins and plasmid DNA.